DIN 02417227 — KAZANO 12.5 MG; 850 MG
KAZANO is a tablet of Alogliptin / Metformin marketed by TAKEDA CANADA INC. The full Alogliptin / Metformin monograph covers indications, dosing, interactions and counselling for every strength and manufacturer.
- DIN
- 02417227
- Brand name
- KAZANO
- Active ingredient
- Alogliptin / Metformin
- Strength
- 12.5 MG; 850 MG
- Dosage form
- TABLET
- Route
- ORAL
- Manufacturer
- TAKEDA CANADA INC
- Health Canada status
- MARKETED
- Drug class
- Combination oral antidiabetic (DPP-4 inhibitor + biguanide)
Product data from the Health Canada Drug Product Database, synced . Verify the live status at Health Canada.
Other Alogliptin / Metformin products
| DIN | Brand | Strength | Form | Manufacturer | Status |
|---|---|---|---|---|---|
| 02417235 | KAZANO | 1000 MG; 12.5 MG | TABLET | TAKEDA CANADA INC | MARKETED |
| 02417219 | KAZANO | 500 MG; 12.5 MG | TABLET | TAKEDA CANADA INC | MARKETED |